Knee Replacement Devices Market: Robotic-Assisted TKA, Cementless Fixation Growth, and Partial Knee Arthroplasty Expansion to Drive Sustained Market Growth Through 2035

The global Knee Replacement Devices market was valued at USD 6.2 billion in 2025 and is projected to reach USD 10.47 billion by 2035, advancing at a CAGR of 6.0%. The market encompasses total knee replacement (TKR) implants including cruciate retaining (CR), posterior stabilized (PS), mobile-bearing, and fixed-bearing designs; partial knee replacement (PKR) implants including medial unicompartmental, lateral unicompartmental, and patellofemoral designs; revision knee replacement implants; patellofemoral replacement implants; and knee fixation components across cemented, cementless, and hybrid fixation. Material categories include metal alloys, cobalt-chromium, titanium alloys, stainless steel, polyethylene, ceramic, and hybrid materials. Procedure types span primary knee replacement, partial knee replacement, and revision knee replacement, with end users spanning hospitals, ambulatory surgery centres, and orthopedic clinics.

The knee replacement devices market is growing above the broader orthopedic implant sector average from three technology-driven market dynamics: the rapid adoption of robotic-assisted total knee arthroplasty platforms that demonstrably improve implant alignment accuracy beyond manual instrumentation, reducing early malalignment-related adverse outcomes; the accelerating penetration of cementless TKA fixation as 10-year registry survivorship data validates biological ingrowth durability and surgeon confidence in cementless technique grows; and the resurgence of partial knee arthroplasty — specifically medial unicompartmental knee arthroplasty — from improved implant survivorship data and robotic-assisted surgical precision that enables bone-conserving unicompartmental surgery with lower revision rates than earlier-generation UKA systems.

Executive Snapshot

How does robotic-assisted TKA improve implant alignment accuracy above conventional manual instrumentation?
Robotic-assisted TKA systems — including Stryker Mako, Smith+Nephew NAVIO, Zimmer Biomet ROSA, and Corin OMNIBotics — register the individual patient’s bone anatomy intraoperatively through either CT-based preoperative planning or intraoperative bone mapping, then provide real-time haptic or visual boundary feedback that constrains bone resection to within the planned resection plane, limiting outlier component positioning beyond the planned mechanical and kinematic alignment parameters. Published prospective and comparative studies demonstrate that robotic-assisted TKA achieves lower rates of component positioning outliers beyond 2 to 3 degrees of planned alignment than manual jig instrumentation, reducing the subset of patients with alignment-related early functional dissatisfaction and implant failure risk.

What is sustaining cementless TKA adoption acceleration from cemented baseline?
Contemporary cementless TKA implant designs — featuring 3D-printed titanium lattice ingrowth surfaces, tantalum trabecular metal surfaces, and plasma-spray hydroxyapatite coatings — have demonstrated 10-year Australian and Swedish registry survivorship rates equivalent to or superior to cemented TKA fixation, while the elimination of polymethylmethacrylate cement from the implantation procedure provides operative time advantages and eliminates the revision cement removal challenge that complicates cemented TKA revision surgery. Cementless TKA is particularly growing in younger patients below 60 years of age where implant longevity over a 20 to 30-year anticipated service life motivates biological fixation over cement, and in revision cases where cementless reconstruction avoids the bone loss associated with cement removal.

How is robotic-assisted partial knee arthroplasty sustaining UKA resurgence above total knee replacement for isolated unicompartmental disease?
Medial unicompartmental knee arthroplasty for isolated medial compartment osteoarthritis preserves the native ACL, lateral compartment, and patellofemoral compartment — bones and ligaments that total knee arthroplasty removes — enabling more natural kinematics, faster functional recovery, and lower early complication rates than TKA in appropriately selected patients with truly isolated compartmental disease. Robotic-assisted UKA has addressed the historical learning curve and implant positioning accuracy challenges that limited conventional manual UKA survivorship, with Mako and NAVIO robotic UKA demonstrating 10-year survivorship rates approaching 90 to 95 percent at high-volume robotic UKA programmes — a significant improvement over conventional manual UKA survivorship reported in historical registry data.

How does the ambulatory surgery centre migration sustain knee replacement device market dynamics?
The addition of total knee arthroplasty to the Medicare ASC-approved procedure list and the development of same-day discharge TKA care pathways have enabled large-volume TKA migration from inpatient hospital settings to ambulatory surgery centres, creating a new high-volume procedure setting that purchases knee implant systems with different packaging, instrument set design, and workflow integration requirements than hospital inpatient TKA programmes. ASC-adapted implant systems with reduced instrument tray counts, single-use sterilisation packaging, and streamlined component families are capturing share at ASCs as manufacturers develop dedicated product configurations optimised for outpatient arthroplasty workflow.

What ceramic and oxidised metal bearing material advances are sustaining premium femoral component revenue?
Oxidised zirconium femoral components — produced by subjecting a zirconium alloy to a thermal oxidation process that converts the outer surface to a ceramic oxide layer 5 microns thick — provide the bearing surface hardness and scratch resistance of ceramic at 50 percent of the ceramic fracture risk, eliminating the catastrophic brittle fracture risk that ceramic femoral components carry in high-impact activities. Oxidised zirconium femoral components paired with highly cross-linked polyethylene tibial inserts demonstrate lower volumetric wear rates than cobalt-chromium femoral components against HXLPE in laboratory testing, sustaining premium oxidised zirconium femoral component pricing above standard cobalt-chromium baseline at activity-focused younger TKA patient programmes.

Which knee replacement device segments are growing fastest?
Robotic-assisted TKA adoption improving alignment accuracy and sustaining premium system and implant revenue, cementless TKA fixation conversion from cemented baseline accelerating at younger patient programmes, robotic UKA resurgence from improved survivorship data above conventional manual UKA, and ASC-adapted knee implant system development from outpatient TKA migration are the four fastest-growing knee replacement device segments.

Market Dynamics: Knee Replacement Devices Market

  • Robotic-assisted TKA alignment accuracy improvement sustaining premium implant and capital system revenue at hospital and ASC arthroplasty programmes.
    Robotic TKA platform adoption sustaining premium implant and capital system revenue from demonstrated alignment accuracy improvement reducing malalignment-related adverse outcomes.
  • Cementless TKA registry survivorship validation and ingrowth surface technology maturation accelerating fixation conversion from cemented baseline at younger patient programmes.
    Cementless TKA adoption sustaining 3D-printed and trabecular metal ingrowth surface implant revenue growth as fixation conversion from cemented baseline accelerates.
  • Robotic UKA survivorship improvement above conventional manual UKA sustaining partial knee arthroplasty resurgence for isolated compartmental disease.
    Robotic UKA adoption sustaining partial knee arthroplasty volume growth from improved survivorship and alignment accuracy above conventional manual UKA historical registry survivorship.
  • ASC TKA migration sustaining demand for simplified instrument set, reduced tray count, and outpatient-adapted knee implant system designs.
    ASC arthroplasty migration sustaining manufacturer investment in ASC-adapted knee implant system configurations optimised for outpatient procedure workflow.
  • Oxidised zirconium and ceramic femoral component premium pricing sustaining above-cobalt-chromium bearing material revenue at younger and activity-focused TKA patient programmes.
    Oxidised zirconium femoral component adoption sustaining premium bearing material revenue above standard cobalt-chromium from wear rate and scratch resistance advantages.
  • Aging population-driven knee osteoarthritis sustaining structural primary TKA volume demand through demographic incidence growth.
    Demographic knee osteoarthritis incidence sustaining long-term structural primary TKA volume demand above technology-adoption-driven replacement cycle dynamics.

Market Segmentation: Knee Replacement Devices Market

By Procedure Type
  • Primary Knee Replacement
  • Partial Knee Replacement
  • Revision Knee Replacement
By Fixation Type
  • Cemented Implants
  • Cementless Implants
  • Hybrid Fixation
By End User
  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Orthopedic Clinics
By Material
  • Metal Alloys
    • Cobalt-Chromium
    • Titanium Alloys
    • Stainless Steel
  • Polyethylene
  • Ceramic
  • Hybrid Materials
By Product Type
  • Total Knee Replacement (TKR) Implants
    • Cruciate Retaining (CR)
    • Posterior Stabilized (PS)
    • Mobile-Bearing
    • Fixed-Bearing
  • Partial Knee Replacement (PKR) Implants
    • Medial Unicompartmental
    • Lateral Unicompartmental
    • Patellofemoral
  • Revision Knee Replacement Implants
  • Patellofemoral Replacement Implants
  • Knee Fixation Components
    • Cemented
    • Cementless
    • Hybrid
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Knee Replacement Devices Market

  1. Robotic TKA alignment accuracy improvement sustaining premium implant and capital system revenue at arthroplasty programmes.
    Robotic arthroplasty adoption sustaining premium revenue from alignment accuracy improvement that reduces malalignment-related adverse outcomes and early revision risk.
  2. Cementless TKA registry validation and ingrowth surface maturation accelerating fixation conversion at younger patient programmes.
    Cementless TKA adoption sustaining 3D-printed and trabecular metal ingrowth surface revenue growth from fixation conversion acceleration.
  3. Robotic UKA survivorship improvement sustaining partial knee arthroplasty resurgence for isolated compartmental disease.
    Robotic UKA adoption sustaining unicompartmental arthroplasty volume growth from improved survivorship and patient outcomes above manual UKA historical registry data.
  4. ASC TKA migration sustaining demand for simplified instrument and outpatient-adapted knee implant system configurations.
    ASC arthroplasty migration sustaining manufacturer investment in outpatient-adapted knee implant system configurations.
  5. Oxidised zirconium and ceramic femoral component premium sustaining above-cobalt-chromium bearing material revenue.
    Oxidised zirconium adoption sustaining premium bearing material revenue at younger and activity-focused TKA programmes valuing wear rate and scratch resistance advantages.
  6. Demographic knee osteoarthritis sustaining structural primary TKA volume demand through aging population incidence growth.
    Aging population knee osteoarthritis incidence sustaining long-term primary TKA volume demand above technology replacement cycle dynamics.

Regional Outlook: Knee Replacement Devices Market

  • North America: The largest knee replacement devices market, driven by the highest global total knee arthroplasty procedure volumes at U.S. hospitals and ambulatory surgery centres, rapid robotic arthroplasty platform adoption sustaining premium implant revenue, strong cementless TKA conversion at younger patient arthroplasty programmes, and CMS ASC coverage facilitating TKA migration to ambulatory settings.
  • Europe: Germany, France, the UK, and Scandinavia anchor European knee replacement device demand, with national arthroplasty registries providing long-term implant survivorship data guiding procurement decisions. Nordic countries have historically higher cementless TKA penetration rates and UKA utilisation rates than the U.S., providing a leading indicator of cementless conversion and UKA resurgence trajectory globally.
  • Asia-Pacific: The fastest-growing regional knee replacement market, driven by Japan’s high TKA volumes from aging population knee osteoarthritis burden, China’s volume-based procurement policy shaping domestic implant competition, India’s growing private orthopedic hospital arthroplasty volumes, and South Korea’s sophisticated robotic arthroplasty capabilities at university hospital joint reconstruction programmes.

Competitive Landscape: Knee Replacement Devices Market

Key Players: Zimmer Biomet (Persona, NexGen), Stryker (Triathlon, Mako), J&J MedTech (ATTUNE, DePuy), Smith+Nephew (Journey II, NAVIO), Exactech (Truliant, Vanguard), MicroPort Orthopedics, Enovis (Colfax), ConforMIS (Patient-Specific Knee), Corin (OMNIBotics Robotic UKA), Waldemar LINK, Endocare Medtech, Aesculap (B. Braun), Tornier (Wright Medical), Biomet (Zimmer Biomet Legacy), 3i Orthopedic, DePuy (J&J Legacy Knee), Advanced Biomedical (Custom Knee), Lepu Medical Technology (China)

  • Stryker confirmed continued global Mako robotic TKA procedure volume growth and reported that Mako-performed total knee arthroplasty now accounts for a growing majority of Stryker knee implant procedures at Mako-installed accounts, with Stryker presenting data showing that accounts with Mako-assisted TKA report above-Stryker-system-average Triathlon knee implant usage rates, confirming that robotic platform adoption sustains knee implant share concentration at converting orthopaedic accounts and drives implant revenue correlated with Mako installation growth.
  • Zimmer Biomet reported accelerating cementless Persona total knee replacement adoption at U.S. and European arthroplasty programmes following publication of 5-year cementless Persona survivorship data demonstrating greater than 96 percent freedom from aseptic loosening at centres employing standardised cementless Persona surgical technique protocols, with Zimmer Biomet noting that the 5-year data are sustaining cementless Persona adoption discussions at cemented TKA dominant accounts that are converting younger patient arthroplasty cohorts to cementless fixation.
  • Corin Group confirmed growing OMNIBotics robotic platform adoption at European and Asia-Pacific orthopaedic practices for both total knee arthroplasty and medial unicompartmental knee arthroplasty, with Corin reporting that OMNIBotics-assisted UKA is generating 5-year survivorship outcomes comparable to published Mako robotic UKA registry data, sustaining adoption at arthroplasty programmes seeking a robotic UKA platform capable of both TKA and UKA applications within a single system installation investment.

Consultant POV

The Knee Replacement Devices market trajectory toward USD 10.47 billion by 2035 at 6.0% CAGR is anchored in robotic TKA adoption driving premium implant revenue, cementless fixation conversion acceleration, UKA resurgence from robotic precision, and ASC migration sustaining market dynamics above procedure volume growth alone. Stryker Mako TKA procedure volume and share concentration, Zimmer Biomet cementless Persona 5-year data adoption, and Corin Group OMNIBotics UKA survivorship data confirm the knee replacement devices market will sustain above-broader-orthopedic-sector growth through 2035.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC